PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-3.43%
Both companies show declining cash positions (-3.43% vs RVPH's -0.92%). Seth Klarman would examine if this reflects broader market conditions or operational challenges.
No Data
No Data available this quarter, please select a different quarter.
-3.43%
Cash + STI yoy ≥ 1.5x RVPH's -0.92%. David Dodd might see it as a strategic cash buffer advantage. Evaluate deployment plans.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
967.92%
Other current assets growth < half of RVPH's -58.05%. David Dodd sees a leaner approach to short-term items.
-3.05%
Below half of RVPH's -8.21%. Michael Burry could suspect a liquidity squeeze. Verify operational performance.
0.98%
Higher PP&E (Net) Growth compared to RVPH's zero value, indicating better performance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Higher Other Non-Current Assets Growth compared to RVPH's zero value, indicating worse performance.
0.98%
Higher Total Non-Current Assets Growth compared to RVPH's zero value, indicating better performance.
No Data
No Data available this quarter, please select a different quarter.
-2.92%
Below half of RVPH's -8.21%. Michael Burry sees a potential red flag for stagnation or capital shortage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-106.99%
Less than half of RVPH's 109.01%. David Dodd sees fewer expansions in other current obligations.
16.37%
Less than half of RVPH's 40.37%. David Dodd sees a more disciplined short-term liability approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.35%
Less than half of RVPH's 82.00%. David Dodd sees a more conservative approach to non-current liabilities.
No Data
No Data available this quarter, please select a different quarter.
2.58%
Less than half of RVPH's 43.62%. David Dodd sees far fewer liability expansions relative to competitor.
3.85%
Less than half of RVPH's 10.76%. David Dodd sees fewer share issuances vs. competitor.
-5.06%
Below half RVPH's -12.73%. Michael Burry suspects major net losses or high dividends vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-7.22%
Below half RVPH's -71.98%. Michael Burry sees potential underperformance in building shareholder capital.
-2.92%
Below half RVPH's -8.21%. Michael Burry sees significant shrinkage or inactivity vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
-5.00%
Less than half of RVPH's -66.67%. David Dodd sees less overall debt expansion vs. competitor.
3.39%
Less than half of RVPH's -3.22%. David Dodd sees better deleveraging or stronger cash buildup than competitor.